Figure 5.
Tumor mutation burden (TMB) of the prospective cohort. Mucinous (MC, n = 9) tumors have higher TMB versus adenocarcinoma cancers (AC, n = 5), p=0.07.
Tumor mutation burden (TMB) of the prospective cohort. Mucinous (MC, n = 9) tumors have higher TMB versus adenocarcinoma cancers (AC, n = 5), p=0.07.